Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 0.4980
+0.0180 (3.75%)
Aug 13, 2026, 2:17 PM CET
STO:MAGLE Market Cap
STO:MAGLE has a market cap or net worth of 15.07 million as of August 13, 2026. Its market cap has decreased by -96.12% in one year.
Market Cap
15.07M
Enterprise Value
356.98M
Revenue
274.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
ChartMarket Cap Chart
Since June 30, 2020, STO:MAGLE's market cap has decreased from 205.10M to 15.07M, a decrease of -92.65%. That is a compound annual growth rate of -34.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 15.07M | -95.85% |
| Dec 30, 2025 | 363.43M | -43.25% |
| Dec 30, 2024 | 640.39M | 135.30% |
| Dec 29, 2023 | 272.16M | -5.97% |
| Dec 30, 2022 | 289.44M | -10.37% |
| Dec 30, 2021 | 322.92M | -29.72% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pila Pharma AB | 61.44M |
| Disruptive Pharma AB | 59.21M |
| 2cureX AB | 51.68M |
| Modus Therapeutics Holding AB | 46.83M |
| Fluicell AB | 40.11M |
| ExpreS2ion Biotech Holding AB | 36.22M |
| Alligator Bioscience AB | 23.62M |
| Aptahem AB | 16.34M |